enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
7.50
-0.02 (-0.27%)
Nov 20, 2024, 4:00 PM EST - Market closed
enGene Holdings Market Cap
enGene Holdings has a market cap or net worth of $382.33 million as of November 21, 2024. Its market cap has increased by 73.48% in one year.
Market Cap
382.33M
Enterprise Value
149.50M
1-Year Change
73.48%
Ranking
Category
Stock Price
$7.50
Market Cap Chart
Since February 1, 2022, enGene Holdings's market cap has increased from $155.91M to $382.33M, an increase of 145.22%. That is a compound annual growth rate of 37.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 382.33M | 78.56% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Canopy Growth | 404.14M |
| 4D Molecular Therapeutics | 400.79M |
| Akebia Therapeutics | 397.09M |
| Revance Therapeutics | 394.43M |
| KalVista Pharmaceuticals | 391.10M |
| Tactile Systems Technology | 378.43M |
| Alector | 377.04M |
| ProQR Therapeutics | 371.53M |